[Ip-health] New BlogPost: Brief Reflections on Biosimilars Medicine Conference, 23-24th March 2017
fifarahman at outlook.com
Wed Apr 12 11:03:38 PDT 2017
My new blog post on affordability and entry of biosimilar medicines, reflecting on the 15th Biosimilar Medicines Conference in London, 23-24th March 2017.
"Uptake of biosimilars, i.e. cost saving highly similar versions of the stiff price reference biologic products, has been slow throughout most of Europe and the rest of the world.
Without express and official government policy purchasing and recommending biosimilars, doctors will not use biosimilars and the resulting cost savings cannot be made."
Sent from my iPhone 6
More information about the Ip-health